bpc-157 fda warning letter unapproved new drug to Great Lakes College of June 8, 2026: Reckless physicians
Description
Schroder TH, Sinclair G, Mattman A, Jung B, Barr SI, Vallance HD, et al
Arch Biochem Biophys 508:112
doi:10.1177/03635465251357593
Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study
